Recombinant CLDN18.2 (Zolbetuximab Biosimilar) anticorps

N° du produit ABIN7581329

Cet anticorps anti-CLDN18.2 (Zolbetuximab Biosimilar) est un anticorps Human Monoclonal détectant CLDN18.2 (Zolbetuximab Biosimilar) dans FACS, BLI, ELISA, Func et SPR. Adapté pour Humain.

Aperçu rapide pour Recombinant CLDN18.2 (Zolbetuximab Biosimilar) anticorps (ABIN7581329)

Antigène: CLDN18.2 (Zolbetuximab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp CLDN18.2 (Zolbetuximab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), ELISA, Functional Studies (Func), Surface Plasmon Resonance (SPR)

Détail du produit anti-CLDN18.2 (Zolbetuximab Biosimilar) anticorps

Expression System: CHO Cells

Fonction: Anti-CLDN18.2 Reference Antibody (zolbetuximab)

Séquence: QVQLQQPGAE LVRPGASVKL SCKASGYTFT SYWINWVKQR PGQGLEWIGN IYPSDSYTNY NQKFKDKATL TVDKSSSTAY MQLSSPTSED SAVYYCTRSW RGNSFDYWGQ GTTLTVSSAS TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKRVEPKS CDKTHTCPPC PAPELLGGPS VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSREEMT KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ GNVFSCSVMH EALHNHYTQK SLSLSPGK,DIVMTQSPSS LTVTAGEKVT MSCKSSQSLL NSGNQKNYLT WYQQKPGQPP KLLIYWASTR ESGVPDRFTG SGSGTDFTLT ISSVQAEDLA VYYCQNDYSY PFTFGSGTKL EIKRTVAAPS VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC

Attributs du produit: Anti-CLDN18.2 Reference Antibody (zolbetuximab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Pureté: >95 %

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

Therapeutic Agents by Target and Mechanism: CLDN18.2 inhibitors, ADCC, complement-dependent cytotoxicity

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Stock: 4 °C,-80 °C

Stockage commentaire: +4°C,-80°C

Détails sur CLDN18.2 (Zolbetuximab Biosimilar)

Antigène: CLDN18.2 (Zolbetuximab Biosimilar)

Classe de substances: Biosimilar

Poids moléculaire: 145.5 kDa

UniProt: P56856